Phreesia Inc PHR

$LFMD $ETON $NXPL $PHR $SURG - which one of the following is gunna explode!!!

$PHR Phreesia put open interest stands at 15.0 https://www.macroaxis.com/stock-options/PHR/Phreesia?utm_source=dlvr.it&utm_medium=stocktwits

DataMeds AI, Inc. (Nasdaq: $MEDS ) has filed DBAs for the names DataMEDS SI and Corexa Health SI, following the U.S. government's updated nomenclature for artificial intelligence. The DBAs were filed for the healthcare company and its Corexa Health subsidiary, and both names carry the SI designation. DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 The two filings cover the parent company and its Corexa Health subsidiary: • DataMEDS SI is filed as a DBA for the parent company, DataMeds AI, Inc., which operates through its Health IT platforms • Corexa Health SI covers the subsidiary that provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health • The parent's own technology includes the artificial intelligence platform EinsteinRx™ and the blockchain-enabled smart contracts platform PharmacyChain™ Gerald Commissiong, Interim Co-CEO of DataMEDS, gave the company's reasoning for the filings. "With rapidly changing policy as it relates to artificial intelligence, including U.S. government nomenclature now referring to it as super intelligence, we felt it was prudent to protect the Company’s branding," he said. Read the full release: https://datamedsai.com/datameds-ai-files-dbas-datameds-si-and-corexa-health-si-and-reminds-shareholders-of-record-as-of-august-7-2026-of-dream-bowl-meme-coin-i-payment/ DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a healthcare company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its Health IT platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into Tollo Health, LLC’s Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including the distribution of products developed by Tollo Health. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer $OPRX, $HCAT, $PHR, $XLV

DataMeds AI, Inc. (Nasdaq: $MEDS ) reported that Corexa Pharmacy, a division of its wholly owned subsidiary Corexa Health, recorded preliminary, unaudited revenue of more than $1 million for September 2026, up more than 66 percent from July 2026. The increase came with an expanding retail customer base and the launch of Tollo Health pharmaceutical-adjunct products, which Corexa Health distributes under a wholesale distribution arrangement. DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 Interim Co-CEO Gerald Commissiong believes Corexa Pharmacy is well positioned for future growth with the Helomics acquisition closed, and the pharmacy's physical location is also being upgraded to serve as a flagship model: • The closing of the Helomics Corporation acquisition opens up potential demand for oncology-based medications and nutritional support products, in Commissiong's view • The company is in the process of upgrading the physical location of Corexa Pharmacy to serve as the flagship model for the Health Lives Here initiative with NFL Alumni Health • Commissiong said the upgraded pharmacy will be presented as a model for other pharmacies within Corexa Health's network of over 6,500 independent pharmacies Regarding the September result, Gerald Commissiong, Interim Co-CEO of DataMeds AI, stated: "With the recent launch of Tollo Health‘s proprietary dietary supplements and medical foods combined with strong organic growth from our growing retail customer base, we are beginning to see the growth in both prescriptions filled and adjunct product sales." Read the full release: https://datamedsai.com/datameds-ais-corexa-pharmacy-surpasses-1-million-in-monthly-revenue/ DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a healthcare company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its Health IT platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into Tollo Health, LLC’s Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including the distribution of products developed by Tollo Health. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $OPRX, $HCAT, $PHR, $XLV

DataMeds AI, Inc. (Nasdaq: $MEDS ) Interim Co-CEO Gerald Commissiong will present "What Patients Really Want" at the 2026 National Telehealth and Virtual Care Summit in Las Vegas on Monday, September 28, 2026 at 9:15 a.m. PT, the company announced September 25. The talk covers the growing desire among patients across the country to own their individual health data. DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 The Health Lives Here mobile app incorporates the company's AI and blockchain platforms, while Corexa Health provides pharmacy services: • Health Lives Here is a campaign and mobile healthcare application that DataMeds AI is advancing together with NFL Alumni Health • The Health Lives Here mobile application incorporates the company's artificial intelligence platform EinsteinRx™ and its blockchain-enabled smart contracts platform PharmacyChain™ • The company's Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including the distribution of products developed by Tollo Health, LLC Regarding a summit that will unite healthcare leaders, clinicians, technology experts and policymakers, Gerald Commissiong, Interim Co-CEO of DataMeds AI, stated: "I look forward to showcasing our team’s work, outlining our vision of how patient ownership of their data will improve patient care while also reducing provider data access frustrations, and interacting with other leading healthcare providers to discuss how to improve healthcare access for those who need it." Read the full release: https://datamedsai.com/datameds-ai-to-present-at-2026-national-telehealth-and-virtual-care-summit/ DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a healthcare company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its Health IT platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including the distribution of products developed by Tollo Health, LLC. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $OPRX $HCAT, $PHR, $XLV

$PHR back to the 9’s? Cmon! Thought we’d be over $14 by now. The market sucks

DataMeds AI, Inc. (Nasdaq: $MEDS ) launched its new corporate website, www.DataMedsAI.com, on September 21, 2026, with the redesigned site aligned to marketing initiatives now pending after two recently announced transactions. The launch follows the company's acquisition of Helomics Corporation's artificial intelligence cancer diagnostics lab from Axe Compute and the settlement of outstanding litigation tied to its 2023 acquisition of Wellgistics, LLC. DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 Both the Helomics closing and the litigation settlement preceded the launch, and Gerald E. Commissiong ties them to the planned Health Lives Here consumer application: • DataMeds acquired Helomics Corporation's artificial intelligence cancer diagnostics lab, a CLIA-certified laboratory, from Axe Compute • The litigation settlement extinguished approximately $19 million in liabilities from the company's balance sheet and retired 364,099 common shares • Interim Co-CEO Gerald E. Commissiong said the Helomics closing and the litigation settlement leave the company ready to launch the Health Lives Here consumer application as it begins telling the DataMeds story to the broader market Regarding the new site, Gerald E. Commissiong, Interim Co-CEO of DataMeds, stated: "Our new corporate website represents the parent company's new branding. We have retooled our marketing efforts to be AI-centric so that we are able to get organic traction online as we begin to draw earned media interest in our story. We intend to soft launch the Health Lives Here app in short order." Read the full release: https://datamedsai.com/datameds-ai-unveils-new-corporate-website/ DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy and pharmacy services, including the distribution of products developed by Tollo Health, LLC. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $OPRX, $HCAT, $PHR, $XLV

I looked at the business behind $PHR (Phreesia, Inc.) for you. Based on financial data and reported results. #PHR